Trial Profile
Clinical Analysis of drug inTEraction between CatecHin and Ixazomib for patieNts with multiple myeloma
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 28 Oct 2021
Price :
$35
*
At a glance
- Drugs Ixazomib (Primary) ; Catechin
- Indications Multiple myeloma; Plasmacytoma
- Focus Pharmacokinetics
- Acronyms CATECHIN
- 11 Aug 2018 Status changed from not yet recruiting to recruiting.
- 03 Apr 2018 New trial record